Tuesday, October 31, 2006

 

Sector Spotlight: Biotech

Today's market looks tired. I anticipate a minor sell off, sometime soon, in order to consolidate recent gains. Plus, every fucker with a podium and an audience is trying to talk the market down. Therefore, I feel the sellers may try to capitalize on the current negative sentiment.

However, if the market does sell off, it will be temporary and an opportunity to add to positions.

Thanks to MRK ripping themselves off, buying RNAI (102% premium), the Biotech sector is abuzz. Frankly, I hate small Biotech. More often than not, they are nothing more than a loaded dice roll, which comes up snake eyes 90% of the time. For example: Look at the action in AVNR today.

However, I do know some people who make a terrific living, gaming the complicated world of Biotech. In my opinion, it makes sense to invest in established names, like: DNA, GILD or CEPH, opposed to the smaller ones.

I am sure many of you have the "next DNA" in mind. If you do, please share.

The following Biotech stocks have mojo:

RNAI +95%
CYTR +19.8%

ALNY +19.7%

BIIB +6.2%

NVAX +8.3%

BCRX +4.7%

NSTK +4.4%

Comments:
The FT has conviction in their report of a bid on BMET. Has trended well since the initial comment, is def on the block. They reported specifics, bidder and price. I think we see news this week, if not today.
 
here's a shot in the dark...sgmo
 
Post a Comment



<< Home

This page is powered by Blogger. Isn't yours?

 Subscribe in a reader

DISCLAIMER: This is a personal web site, reflecting the opinions of its author. It is not a production of my employer, and it is unaffiliated with any FINRA broker/dealer. Statements on this site do not represent the views or policies of anyone other than myself. The information on this site is provided for discussion purposes only, and are not investing recommendations. Under no circumstances does this information represent a recommendation to buy or sell securities.